Murthy SN, Hilaire RC, Casey DB, Badejo AM, McGee J, McNamara DB, Kadowitz PJ, Fonseca VA: The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats
| Ohio State Medical Center - YouTube, accessed April 21, 2025, Study identifies 3 strategies to minimize muscle loss from GLP-1 weight loss drugs, accessed April 21, 2025, pmc.ncbi.nlm.nih.gov, accessed April 21, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 21, 2025, Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists - Frontiers, accessed April 21, 2025, Effects of Weight Loss on Lean Mass, Strength, Bone, and Aerobic Capacity - PMC, accessed April 21, 2025, Preserving Healthy Muscle during Weight Loss - PMC, accessed April 21, 2025, Boosting BCL6 may counteract muscle loss from GLP-1 medications, accessed April 21, 2025, Muscle Loss and GLP-1s: Why It Matters and How To Address It - Vori Health, accessed April 21, 2025, Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies - PubMed, accessed April 21, 2025, Semaglutide and GLP-1: Effects on lean body mass still unclear, accessed April 21, 2025, Normative vs Excess Muscle Loss and Strength with GLP-1 Medications vs Other Weight Loss Methods - Ro, accessed April 21, 2025, Does Ozempic cause muscle loss and how to prevent it
At JosephCareRX, we are dedicated to providing personalized, evidence-based medical care tailored to your individual health needs
It was the first kind of drug which was used for diabetes treatment through the GLP-1 receptor. Over time, the scientists and the pharmaceutical industry figured out how to make synthetic GLP-1 last longer in the body through the use of other molecule agonists
